MedTrace Logo

The Diabetes Staging System in Patient Aligned Care Teams

NCT06142006 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2024-04-15

No results posted yet for this study

Summary

The purpose of this study is to examine the feasibility/acceptability of the Diabetes Staging System (DSS) in Patient Aligned Care Teams (PACT) teams and its ability to increase sodium-glucose cotransporter-2 inhibitor (SGLT2i) and glucagon-like-1 peptide (GLP-1) use in Veteran patients with type 2 diabetes and cardiovascular disease and/or chronic kidney disease.

Conditions

Interventions

OTHER

Diabetes Staging System (DSS) use among Primary Care Teams

Evaluate the feasibility of using the DSS in PACT clinics to increase SGLT2i and/or GLP-1 agonist use in Veteran DM2 patients with cardiovascular disease

Sponsors & Collaborators

  • Durham VA Medical Center

    lead FED

Principal Investigators

  • Moahad S Dar, MD · Department of Veterans Affair, Durham VAHCS

Eligibility

Min Age
25 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2024-09-01
Completion
2025-09-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06142006 on ClinicalTrials.gov